Tarka Elizabeth Ann 4
4 · IDERA PHARMACEUTICALS, INC. · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Tarka Elizabeth Ann
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-01-08+51,000→ 51,000 totalExercise: $4.28Exp: 2031-01-08→ Common Stock (51,000 underlying) - Sale
Common Stock
2021-01-12$4.19/sh−1,745$7,310→ 18,255 total
Footnotes (3)
- [F1]Represents the number of shares of Issuer common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 5,000 Restricted Stock Units ("RSUs") on January 10, 2021. This sale is mandated by the Issuer's election under its 2013 Stock Incentive Plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]Of the reported securities beneficially owned, 15,000 shares are represented by unvested RSUs.
- [F3]The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 8, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer.